The Cannabinoid-Like Compound, VSN16R, Acts on Large Conductance, Ca

Setareh Tabatabaee, David Baker, David L Selwood, Benjamin J Whalley, Gary J Stephens

Open access · goldAbstract read

In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it

0cells of the map it votes in

3citing papers in PubMed

0.4field-weighted citation impact, top 43% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

SPG601-associated modulation of resting-state EEG and improvement in executive function in a fragile X syndrome randomized controlled crossover study.Scientific reports · 2026
Trial
Reversal of behavioural phenotype by the cannabinoid-like compound VSN16R in fragile X syndrome mice.Brain : a journal of neurology · 2022
Article
Oligodendrocytes, BK channels and the preservation of myelin.F1000Research · 2021
Review

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Setareh TabatabaeeReading School of Pharmacy, University of Reading, Reading RG6 6AP, UK.

David BakerCentre for Neuroscience and Trauma, Blizard Institute, Queen Mary University of London, London E1 4AT, UK.

David L SelwoodDepartment of Medicinal Chemistry, UCL Wolfson Institute for Biomedical Research, University College London, London WC1E 6BT, UK.ORCID 0000-0002-6817-5064

Benjamin J WhalleyReading School of Pharmacy, University of Reading, Reading RG6 6AP, UK.

Gary J StephensReading School of Pharmacy, University of Reading, Reading RG6 6AP, UK. g.j.stephens@reading.ac.uk.

University of Reading · GBQueen Mary University of London · GBUniversity College London · GB

Funding

Medical Research Council MC_PC_13037

6 · The paper itself

Abstract

Large conductance, Ca

Indexed as

7-pra-martentoxinBKCa channelscannabinoidhippocampal pyramidal neuronsVSN16R

Identifiers

PMID31277369

DOI10.3390/ph12030104

PMCPMC6789497

OpenAlexW2956037988

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.